Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials
Author(s) -
Ryan E. Malosh,
Emily T. Martin,
Terho Heikkinen,
W. Abdullah Brooks,
Richard J. Whitley,
Arnold S. Monto
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix1040
Subject(s) - medicine , oseltamivir , randomized controlled trial , population , adverse effect , placebo , otitis , confidence interval , pediatrics , surgery , disease , alternative medicine , environmental health , covid-19 , pathology , infectious disease (medical specialty)
Oseltamivir has been used to treat children with influenza for nearly 2 decades, with treatment currently approved for infants aged ≥2 weeks. However, efficacy and safety remain controversial. Newer randomized, placebo-controlled trials (RCTs), not included in previous meta-analyses, can add to the evidence base.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom